Aptar Pharma Celebrates North America Capacity Expansion - Sept 24th
The Congers, New York site supports the development and manufacturing of drug delivery systems, including the proprietary Unidose (UDS) Nasal Spray Systems used for the opioid reversal drug naloxone, including Narcan®, and the recently FDA-approved neffy® (epinephrine nasal spray), the first and only needle-free treatment approved by the U.S. FDA for the emergency treatment of patients with allergic reactions (Type I), including anaphylaxis. This facility also manufactures drug delivery solutions for the treatment of migraines, depression, diabetes, epilepsy, allergies and more.
LTP Price at posting:
$1.74 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)